HMP Global Acquires Proximity Health, LLC

HMP Global Acquires Drug Channels Institute

January 4, 2024

Healthcare Services

HMP Global has entered into a definitive agreement to acquire Drug Channels Institute (DCI), a provider of pharmaceutical market intelligence and analysis. The acquisition will fold DCI into HMP Market Access Insights to create a new market intelligence division, expanding HMP Global's research capabilities and services for clients across the pharmaceutical ecosystem.

HMP Global Acquires Psychiatry Redefined

September 22, 2025

Healthcare Services

HMP Global has acquired Psychiatry Redefined, a clinician-focused educational platform founded by Dr. James Greenblatt that integrates traditional psychopharmacology with functional, nutritional, and integrative psychiatry. The acquisition expands HMP Global’s psychiatry and behavioral health portfolio and aims to scale whole-patient, personalized psychiatry education to clinicians worldwide.

HMP Global Acquires Kestrel Health Information

March 23, 2021

Healthcare Services

HMP Global has agreed to acquire Kestrel Health Information, the producer of WoundCon and owner of the WoundSource Directory, adding wound-care-focused virtual conference and content assets to HMP's portfolio. The deal expands HMP Global's wound care education reach across virtual, digital, and print formats and strengthens its clinician networks and educational offerings.

HGI Clinical / Billy Howell Acquire Proxima Clinical Research

November 6, 2025

Healthcare Services

Proxima Clinical Research, a Houston-based MedTech-focused contract research organization (CRO), has been acquired in a change of ownership led by Billy Howell with close ties to HGI Clinical. Eric Ross was appointed CEO following the transaction; the buyer intends to integrate Proxima with HGI Clinical to create a stronger MedTech/biotech CRO platform.

Pro-ficiency Acquires Compass Group Partners

June 30, 2023

Healthcare Services

Pro-ficiency has acquired Compass Group Partners and affiliated assets to combine its simulation-based training platform with Compass's life-sciences medical communications capabilities. The deal expands Pro-ficiency's simulation offerings into medical affairs and commercial markets, enabling immersive simulation solutions for pharma and biotech customers and creating new revenue opportunities.

Genomate Health Acquires Oncompass Medicine

January 14, 2026

Healthcare Services

Genomate Health, a Cambridge-based precision medicine company, has acquired Hungarian personalized oncology firm Oncompass Medicine to expand its precision-oncology offerings and establish a stronger presence in Europe. The acquisition brings Oncompass's oncology decision‑support capabilities and customer relationships into Genomate's computational precision‑medicine platform.